Study Confirms Elucid’s AI Software Accurately Estimates Lesion-Specific Ischemia Compared to Standard of Care
BOSTON–(BUSINESS WIRE)–#artificialintelligence–Elucid, a medical technology company developing AI software to enable cardiovascular disease detection, announced…